LMR Partners’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,671,707
Closed -$19.6K 1411
2023
Q4
$19.6K Hold
1,671,707
﹤0.01% 839
2023
Q3
$61.7K Hold
1,671,707
﹤0.01% 716
2023
Q2
$76.2K Hold
1,671,707
﹤0.01% 637
2023
Q1
$402K Hold
1,671,707
0.01% 749
2022
Q4
$1.17M Buy
1,671,707
+753,295
+82% +$103K 0.02% 658
2022
Q3
$1.71M Buy
918,412
+147,527
+19% +$40.5K 0.03% 582
2022
Q2
$1.63M Buy
770,885
+313,878
+69% +$186K 0.03% 593
2022
Q1
$2.4M Buy
457,007
+423,674
+1,271% +$413K 0.03% 512
2021
Q4
$517K Buy
+33,333
New +$56.7K 0.01% 880

Other funds holding HLGN.WS

LMR Partners's HLGN.WS Position: Q1 2024 in Review

LMR Partners sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q1 2024, closing a stake of 1,671,707 shares — an estimated $19.6K sold.

LMR Partners first reported a position in HLGN.WS in Q4 2021 and held it in 9 quarters. The position peaked at $2.4M in Q1 2022. 1 fund tracked by Wall St. Rank holds HLGN.WS as of Q1 2024.

  • LMR Partners reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q1 2024 after selling out during the quarter.
  • LMR Partners sold 1,671,707 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q1 2024, an estimated $19.6K.
  • LMR Partners first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 9 quarters.
  • LMR Partners's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $2.4M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.